MyFinsight
Home
About
Contact
Back
Income Statement
Aclaris Therapeutics, Inc. (ACRS)
source: myfinsight.com
Download
Download image
Unrealized gain (loss) on
marketable securities, net...
$48K
(148.48%↑ Y/Y)
Comprehensive loss
-$15,381K
(-38.76%↓ Y/Y)
Total other
comprehensive income (loss)
$48K
(148.48%↑ Y/Y)
Interest income
$2,018K
Non-cash royalty income
$961K
Contract Research
Segment
$442K
Dermatology Therapeutics
Segment
$1,335K
Net loss
-$15,429K
(-40.44%↓ Y/Y)
Total other income
$2,979K
Revenue from contract
with customer,...
$3,520K
Revenue from contract
with customer,...
$1,777K
Loss from operations
-$18,408K
(-43.21%↓ Y/Y)
Total revenue
$1,777K
(-35.76%↓ Y/Y)
Revenue from contract
with customer,...
-$3,520K
Total costs and
expenses
$20,185K
(29.23%↑ Y/Y)
Licensing
$1,335K
(3.89%↑ Y/Y)
Revaluation of contingent
consideration
$1,500K
(650.00%↑ Y/Y)
Cost of revenue
$515K
(-17.47%↓ Y/Y)
General and
administrative
$5,386K
(13.34%↑ Y/Y)
Research and development
$11,449K
(30.71%↑ Y/Y)
Back